Z Squared Inc.
ZSQRNasdaq
$5.06
↓ -7.2%Jul 17 close · end-of-day
Price
1Y↓ -48.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$30.5M
Enterprise Value
$30.6M
P/E
—
P/S
21.6
P/B
1.8
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$1.4M
Net Income (TTM)
-$12.5M
Free Cash Flow (TTM)
—
Gross Margin
87.2%
Operating Margin
-912.4%
Net Margin
—
ROE
—
ROIC
-59.0%
Debt / Equity
0.0
Net Cash
-$99,449.00
Return 1Y
-55.1%
Company profile
Bull Horn Holdings Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was founded in 2018 and is based in Miami Beach, Florida.
- CEO
- David Mehalick
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 2
- Headquarters
- Pennsylvania
- Website
- coeptispharma.com
Management & directors
- Burke Michelle EllenCo-Chief Executive Officer
- Cogley BrianChief Financial Officer
- Mehalick DavidCEO and President
- Sheehy Christine EliseVP Compliance and Secy
- Yerace Daniel AlexanderVP Operations
Roles derived from SEC Form 4 filings.
Earnings
ZSQR Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$113,771.00↑ +81.0%
Diluted EPS-$0.65↓ -40.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $75,000.00 | $0.00 | $0.00 | $0.00 | $1.4M |
| Gross profit | — | $75,000.00 | $0.00 | $0.00 | $0.00 | $1.2M |
| Operating income | -$68,430.00 | -$14.0M | -$34.2M | -$21.5M | -$10.1M | -$13.0M |
| Net income | -$17.3M | -$13.4M | -$37.6M | -$21.3M | -$10.7M | -$11.9M |
| Diluted EPS | — | -$1.23 | -$2.63 | -$16.56 | -$5.56 | -$2.81 |
| Operating cash flow | -$115,695.00 | -$4.5M | -$3.9M | -$7.2M | -$6.6M | -$8.6M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | — | 100.0% | — | — | — | 86.7% |
| Operating margin | — | -18727.9% | — | — | — | -956.9% |
| Net margin | — | -17932.4% | — | — | — | -874.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $62,874.00 | $200,681.00 | $237,441.00 | $862,049.00 | $113,771.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $17,718.00 | $155,524.00 | $192,286.00 | $816,892.00 | $68,615.00 |
| Operating income | -$2.8M | -$2.1M | -$2.2M | -$4.1M | -$4.5M | -$2.5M | -$2.0M | -$3.9M |
| Net income | -$3.0M | -$1.8M | -$2.8M | -$3.4M | -$4.3M | -$2.9M | -$1.3M | -$4.0M |
| Diluted EPS | -$0.08 | -$0.05 | -$5.35 | -$1.10 | -$1.17 | -$0.58 | $0.04 | -$0.65 |
| Operating cash flow | -$1.4M | -$1.9M | -$1.4M | -$2.4M | -$2.4M | -$2.2M | -$1.7M | -$1.8M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | 28.2% | 77.5% | 81.0% | 94.8% | 60.3% |
| Operating margin | — | — | — | -6452.6% | -2252.9% | -1043.2% | -230.6% | -3440.8% |
| Net margin | — | — | — | -5440.9% | -2159.9% | -1220.8% | -146.5% | -3534.2% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-30 | BSG Series CM, LLC | J | 41,521,276 | $0.00 | $0.00 | filing |
| 2026-04-27 | Burke Michelle Ellen· Co-Chief Executive Officer | Award | 16,447 | $0.00 | $0.00 | filing |
| 2026-02-11 | Mehalick David· CEO and President | Option exercise | 148,875 | $7.05 | $1.0M | filing |
| 2026-02-11 | Cogley Brian· Chief Financial Officer | Option exercise | 10,000 | $10.56 | $105,600.00 | filing |
| 2026-02-11 | Yerace Daniel Alexander· VP Operations | Option exercise | 10,000 | $10.41 | $104,100.00 | filing |
| 2026-02-11 | Deschamps Philippe | Option exercise | 5,700 | $10.56 | $60,192.00 | filing |
| 2026-02-11 | DeSilva Tara | Option exercise | 5,700 | $10.56 | $60,192.00 | filing |
| 2026-02-11 | Calise Chris | Option exercise | 5,700 | $10.56 | $60,192.00 | filing |
| 2026-02-11 | Salkind Gene | Option exercise | 5,700 | $10.56 | $60,192.00 | filing |
| 2026-02-11 | Calise Chris | Option exercise | 5,700 | $10.56 | $60,192.00 | filing |
| 2026-02-11 | Cochran Christopher P. | Option exercise | 5,700 | $10.56 | $60,192.00 | filing |
| 2026-02-11 | Sheehy Christine Elise· VP Compliance and Secy | Option exercise | 1,000 | $10.56 | $10,560.00 | filing |
| 2026-02-11 | Sheehy Christine Elise· VP Compliance and Secy | Award | 12,500 | $0.00 | $0.00 | filing |
| 2026-02-11 | Cogley Brian· Chief Financial Officer | Award | 12,500 | $0.00 | $0.00 | filing |
| 2026-02-11 | Deschamps Philippe | Award | 3,250 | $0.00 | $0.00 | filing |
| 2026-02-11 | Calise Chris | Award | 3,250 | $0.00 | $0.00 | filing |
| 2026-02-11 | Calise Chris | Award | 3,250 | $0.00 | $0.00 | filing |
| 2026-02-11 | Mehalick David· CEO and President | Award | 51,250 | $0.00 | $0.00 | filing |
| 2026-02-11 | Cochran Christopher P. | Award | 3,250 | $0.00 | $0.00 | filing |
| 2026-02-11 | Yerace Daniel Alexander· VP Operations | Award | 20,000 | $0.00 | $0.00 | filing |
| 2026-02-11 | Salkind Gene | Award | 3,250 | $0.00 | $0.00 | filing |
| 2026-02-11 | DeSilva Tara | Award | 3,250 | $0.00 | $0.00 | filing |
Latest 22 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.